A new grammar for drug discovery

Mark C. Fishman () and Jeffery A. Porter
Additional contact information
Mark C. Fishman: Novartis Institutes for BioMedical Research
Jeffery A. Porter: Novartis Institutes for BioMedical Research

Nature, 2005, vol. 437, issue 7058, 491-493

Abstract: To realize the potential of the genome for identifying candidate drugs we must move beyond individual genes and proteins. The signalling pathways in cells provide the right level for such analyses.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/437491a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:437:y:2005:i:7058:d:10.1038_437491a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/437491a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().